Stay updated on Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site underwent a small frontend revision, upgrading from v3.6.5 to v3.6.6, indicating an incremental update to the interface and internal components rather than substantive changes to study details.
    Difference
    0.0%
    Check dated 2026-09-02T18:13:07.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a line in the Study Details noting the 2015 NIH grant/contract, linking the study to NIH funding information.
    Difference
    0.0%
    Check dated 2026-08-26T19:44:28.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision tag, v3.6.5, was added to the page, replacing the previous v3.6.4 and signaling a small update to the page's versioning.
    Difference
    0.0%
    Check dated 2026-08-12T09:20:32.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.3 to v3.6.4, representing a small update to the page metadata. This change does not modify the study details or other content visible to users.
    Difference
    0.0%
    Check dated 2026-07-21T23:25:13.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page’s revision metadata was updated from v3.6.0 to v3.6.3, reflecting a minor update to the page that does not alter the study data or results.
    Difference
    0.0%
    Check dated 2026-06-30T10:29:47.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The study page adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). It also notes that recruitment has ended and updates the page version to v3.6.0, including a change to the Intervention/Treatment label.
    Difference
    0.2%
    Check dated 2026-06-16T00:31:17.000Z thumbnail image

Stay in the know with updates to Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.